Curtis Ulleseit v. Bayer Corp.

Good Law
United States Court of Appeals for the Ninth CircuitDecember 29, 202119-15778California1,551 words

Opinion

Opinion

NOT FOR PUBLICATION FILED

UNITED STATES COURT OF APPEALS DEC 29 2021

MOLLY C. DWYER, CLERK

U.S. COURT OF APPEALS

FOR THE NINTH CIRCUIT

CURTIS ULLESEIT; LISA WEHLMANN, No. 19-15778

Plaintiffs-Appellees, D.C. No. 3:17-cv-07026-JD

v.

MEMORANDUM*

BAYER HEALTHCARE

PHARMACEUTICALS INC.; et al.,

Defendants-Appellants,

and

BAYER PHARMA AG, FKA Bayer Schering Pharma AG; et al.,

Defendants.

BETH WINKLER, No. 19-15782

Plaintiff-Appellee, D.C. No. 3:18-cv-03077-JD

v.

BAYER HEALTHCARE

PHARMACEUTICALS INC.; et al.,

Defendants-Appellants,

* This disposition is not appropriate for publication and is not precedent except as provided by Ninth Circuit Rule 36-3. Page 2 of

and

MCKESSON CORPORATION;

MCKESSON MEDICAL-SURGICAL INC.,

Defendants.

On Remand From the United States Supreme Court

Argued and Submitted December 8, 2021 San Francisco, California

Before: WATFORD, FRIEDLAND, and MILLER, Circuit Judges. Dissent by Judge MILLER

Bayer HealthCare Pharmaceuticals Inc., Bayer Corporation, and Bayer

Healthcare LLC (collectively, Bayer) appeal from…

Sign in to read the full opinion

Create a free account to read the complete opinion text, citation history, and good-law status for this case.